Lv5
1000 积分 2021-12-09 加入
Analysis of CCND3 mutations in diffuse large B-cell lymphoma
9小时前
已完结
A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma
13小时前
求助中
Mantle cell lymphoma: is it time for risk-adapted treatment?
22小时前
已完结
Frontline Treatment of Mantle Cell Lymphoma
2天前
已完结
High-Risk MCL: Recognition and Treatment
2天前
已完结
Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase–Targeted Approaches
2天前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
2个月前
已完结
DLBCL: Who is high risk and how should treatment be optimized?
2个月前
已完结
EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management
3个月前
已完结
Unusual fatty metamorphosis observed in diffuse liver metastases of stage 4S neuroblastoma
4个月前
已完结
皖公网安备34019202002308
